The strength of Aderis Pharmaceuticals rests in our diverse scientific knowledge and expertise. Our management, board and scientists have extensive backgrounds and experience in discovering, developing, conducting clinical trials and commercializing pharmaceutical products.

Platform Programs - With established research and development of small molecules acting at subtypes of adenosine receptors, dopamine receptors as well as leukotriene pathways, Aderis has substantial intellectual and scientific knowledge that provides the foundation of our expanding drug candidate pipeline.

Clinical Development - Our experienced staff of well-respected clinicians provide extensive expertise in the clinical development process. Aderis internally manages clinical trials on several of its candidates and participates in the management of other trials with its strategic partners. We will draw on our expertise to retain development responsibility of our internal drug candidates and newly in-licensed clinical stage drug candidates through commercialization.

Drug Discovery - Aderis has made key investments to expand our clinical pipeline by the addition of state-of-the-art laboratory facilities and personnel to enhance our in-house expertise in synthetic chemistry and pharmacology.

back to top

---